VAD
This review explores the application of invasive hemodynamic assessments in the personalization of care for patients with left ventricular assist devices (LVADs). The authors provide a comprehensive approach to their use in triaging patients with...
This study analyzed 3,394 pediatric congenital heart disease (CHD) patients listed for heart transplant from 2014 to 2023. Of these, 16.5 percent received ventricular assist device (VAD) support while waitlisted....
The opening manuscript on the expected series of American Society of Nuclear Cardiology Imaging Indications. For the cardiovascular surgeon, Tables 2 and 7 offer an update on the use of...
This article presents a succinct but comprehensive expert viewpoint on support in cardiogenic shock using the manuscript of the DanGer trial on promising results of Impella in a highly selected...
This review explores the application of invasive hemodynamic assessments in the personalization of care for patients with left ventricular assist devices (LVADs). The authors provide a comprehensive approach to their...
The Impella RP device was approved by the FDA for use as a temporary percutaneous assist for the right ventricle, as announced by Abiomed. Use is approved for up to...
A stimulating editorial triggered by tri-species autopsy work on angiodysplasia potentially attributable to continuous-flow LVAD. Dr Birks discusses the findings and appears open to the suggestion that LVAD per se...
The authors queried the UNOS heart transplantation database to determine if LVAD device-related complications (DRCs) were associated with worse postoperative graft survival. The 5 categories of DRCs were as follows:...
Changes in end organ function were assessed in 59 pts having a continuous flow LVAD in place for more than 3 years. Renal and hepatic function improved initially, but renal...
The authors reviewed the retrospective INTERMACS database to assess whether outcomes after continuous-flow (CF) LVAD implantation varied with patient BSA. A total of over 10,000 CF LVAD patients were included....
The authors of this review article offer an approach to the utilization of a contempory mechanical circulatory support devices. They further provide insights of the key role that well-functioning interdisciplinary...
Rajamiyer Venkateswaran of Mythenshawe Hospital, Manchester, UK, discusses temporary mechanical circulatory support as a bridge to transplantation in cases of cardiogenic shock. Dr. Venkateswaran covers the pathophysiology and strategies for...
With the everpresent question of potentially extending LVAD therapy to ambulatory patients with advanced heart failure, the authors–using a Markov model–projected the incremental cost-efffectiveness ratio (ICER) of DT LVADs in...


